Evaluating the clinical accuracy of GlucoMen®Day: a novel microdialysis-based continuous glucose monitor.

Background: The objective of this work was to determine the clinical accuracy of GlucoMen®Day, a new microdialysis-based continuous glucose monitoring system (CGMS) from A. Menarini Diagnostics (Florence, Italy). Accuracy evaluation was performed using continuous glucose-error grid analysis (CG-EGA), as recommended by the Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline (POCT05-A).

Cystatin C reference values and aging.

Objectives: The aim of this study was to determine the reference values for serum cystatin C (CysC) with a particular focus on the effect of aging.

Design And Methods: The study was performed on a consecutive series of subjects (258 men and 396 women). Laboratory parameters and a detailed personal and family medical history were collected.